Open-to-Accrual Therapeutic Trials


ImmunOTherapy

Protocol ID

Official Title

PI Name

Lead CRC

Disease Site

Phase

KW-0761-012

ClinicalTrials.gov:

NCT02301130

Phase 1 Study of Mogamulizumab (KW-0761) in Combination with MEDI4736 and Mogamulizumab in Combination with Tremelimumab in Subjects with Advanced Solid Tumors A. Nayak Lisa Marshall & Kelly Jenkins Solid Tumor I

NLG-2105

ClinicalTrials.gov: 

NCT02502708

Phase 1 Trials of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors T. Johnson Robin Dobbins & Kimberly Gray Pediatric Brain Tumor I

Tesaro

ClinicalTrials.gov:

NCT02715284

Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors S. Ghamande Lisa Marshall & Kelly Jenkins Solid Tumor I

KW-0761-014

ClinicalTrials.gov:

NCT02705105

Open-label, Multicenter, Phase 1/2 Study of Mogamulizumab in Combination with Locally Advanced or Metastatic Solid Tumors A. Nayak Lisa Marshall & Kelly Jenkins Solid Tumor I/II

NLG-2104

ClinicalTrials.gov:

NCT02077881

A Phase 1/2 Study of Indoximond in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas A. Nayak Lisa Marshall Pancreatic Adenocarcinoma I/II